[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336989-105":59,"doc-detail-336989-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","tm4sf4-is-a-diagnostic-biomarker-accelerating-progression-of-papillary-thyroid-cancer-via-akt-pathway","TM4SF4 is a diagnostic biomarker accelerating progression of papillary thyroid cancer via AKT pathway","","Papillary thyroid cancer incidence rises steadily, yet its molecular drivers remain insufficiently explained. This study investigates TM4SF4’s biological role in PTC progression through differential expression, diagnostic performance, and mechanistic validation. TM4SF4 is significantly upregulated in PTC, functioning as a diagnostic biomarker supported by clinical analyses and ROC. TM4SF4-related enrichment implicates cell junction and cohesion, with immune activation positively associated. TM4SF4 knockdown suppresses proliferation and metastasis while inducing apoptosis, and AKT activation by SC79 reverses these effects, implicating the AKT pathway in TM4SF4-driven malignancy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tm4sf4-is-a-diagnostic-biomarker-accelerating-progression-of-papillary-thyroid-cancer-via-akt-pathway/336989/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tm4sf4-is-a-diagnostic-biomarker-accelerating-progression-of-papillary-thyroid-cancer-via-akt-pathway/336989.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What evidence shows TM4SF4 is upregulated in papillary thyroid cancer?","Question",{"text":112,"@type":113},"Differential expression analysis indicates TM4SF4 is significantly upregulated in PTC. The result is corroborated in a local cohort and by Human Protein Atlas data.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does TM4SF4 contribute to diagnosis of PTC?",{"text":117,"@type":113},"Clinical characteristic analyses and receiver operating characteristic (ROC) curves demonstrate TM4SF4 as a significant diagnostic marker for papillary thyroid cancer.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanistic link connects TM4SF4 to PTC progression?",{"text":121,"@type":113},"In vitro TM4SF4 downregulation suppresses proliferation and metastasis and induces apoptosis. The AKT activator SC79 reverses these suppressed malignant behaviors, suggesting TM4SF4 promotes PTC progression via the AKT pathway.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336989,1790930357,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","RESEARCH PAPER  \nTM4SF4 is a diagnostic biomarker accelerating progression of papillary thyroid cancer via AKT pathway  \nLizhi Lina,b, Jialiang Wenc, Tiansheng Xud, and Yuhao Si d,e  \naDepartment of Surgery, Clinical Sciences Lund, Lund University, Lund, Sweden; bDepartment of Gastrointestinal Surgery, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China; cDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, PR China; dDepartment of Anorectal Surgery, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou, Zhejiang, PR China; e Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, PR China  \nABSTRACT  \nThe incidence of papillary thyroid cancer (PTC) has been steadily rising, though the underlying mechanism remains unclear. This study aims to elucidate the biological role of TM4SF4 in the PTC progression. Our differential expression analysis indicated that TM4SF4 was significantly upregulated in PTC, which was corroborated in both our local cohort and the data from Human Protein Atlas. Additionally, clinical characteristics analysis and receiver operating characteristic curves (ROC) demonstrated that TM4SF4 served as a significant diagnostic marker for PTC. Correlation and enrichment analysis of TM4SF4-related partners suggested that it was involved in cell junction and cohesion processes. Furthermore, immune infiltration analysis revealed a positive correlation between TM4SF4 expression and the immune activation in PTC. Importantly, in vitro experiments demonstrated that TM4SF4 downregulation suppressed the proliferation and metastasis of PTC cell lines while inducing apoptosis. We further discovered that the AKT activator SC79 was able to reverse the malignant behaviors suppression caused by TM4SF4 knockdown, suggesting that TM4SF4 may promote PTC progression via the AKT pathway. In conclusion, our study highlights the oncogenic role of TM4SF4 in PTC and identifies it as a novel biomarker for diagnosis and treatment.  \nARTICLE HISTORY  \nReceived 16 June 2024 Revised 27 October 2024 Accepted 28 October 2024  \nKEYWORDS  \nTM4SF4; diagnostic biomarker; papillary thyroid cancer; AKT  \nIntroduction  \nPapillary thyroid cancer (PTC) is the most common endocrine malignancy, constituting approximately 80% of all thyroid cancers.1 Over the last 30 years, PTC incidence has steadily increased; meanwhile, the advancements in diagnostic technologies such as ultrasonography and computed tomography have led to a massive detection of subclinical lesions.2,3 Although the 10-year survival rate post-surgery exceeds 90%, a substantial portion of PTC patients (35%) experience recurrence due to early lymph node metastasis.4,5 Therefore, it is urgent to unravel the molecular mechanism of PTC carcinogenesis and discover novel therapeutic targets.  \nTransmembrane 4 L Six family member 4(TM4SF4), a member of the transmembrane 4 superfamily, was initially identified in the human intestinal epithelium and liver asa gene associated with cell proliferation.6 Overexpression of TM4SF4 has been observed in hepatocellular carcinoma, leading to increased cell proliferation.7 Targeting TM4SF4 has shown promise as a potential treatment for inhibiting liver cancer.8,9 Furthermore, TM4SF4 has been implicated in the epithelial–mesenchymal transition (EMT) process and has been shown to promote the progression of colorectal cancer.10, 11 Additional research has highlighted the potential of TM4SF4 in lung and breast cancer treatment. 12 However,  \nthe functional role of TM4SF4 in PTC progression remains unexplored.  \nIn our research, we identified a significant upregulation of TM4SF4 in PTC and analyzed its diagnostic potential. We performed correlation and enrichment analysis of TM4SF4-related partners and explored the relationship between TM4SF4 expression and immune cell infiltration. Subsequen","cbCaisYLhKZDow2q","https://ap.wps.com/l/cbCaisYLhKZDow2q","pdf",6103375,14,"English","# Introduction\n## Methods and materials\n### Data acquisition and analysis","[{\"question\":\"What evidence shows TM4SF4 is upregulated in papillary thyroid cancer?\",\"answer\":\"Differential expression analysis indicates TM4SF4 is significantly upregulated in PTC. The result is corroborated in a local cohort and by Human Protein Atlas data.\"},{\"question\":\"How does TM4SF4 contribute to diagnosis of PTC?\",\"answer\":\"Clinical characteristic analyses and receiver operating characteristic (ROC) curves demonstrate TM4SF4 as a significant diagnostic marker for papillary thyroid cancer.\"},{\"question\":\"What mechanistic link connects TM4SF4 to PTC progression?\",\"answer\":\"In vitro TM4SF4 downregulation suppresses proliferation and metastasis and induces apoptosis. The AKT activator SC79 reverses these suppressed malignant behaviors, suggesting TM4SF4 promotes PTC progression via the AKT pathway.\"}]","TM4SF4 is a diagnostic biomarker accelerating progression of papillary thyroid cancer via AKT pathway | PDF",1790017320,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/022b259321abc45e6ec2c375f4726b38.webp",983,1280,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b32f888e227a74bd68ebd4a46aa3c984.webp",982,1278,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/36b446ce7a267d34f58b1e9bc0fe8133.webp",981,1277,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73e62370f7f5ad2e6873bd51c6948126.webp",980,1276]